Your cart is empty.

Browse Categories


Search


Stay In Touch


Login



CBI's 6th Annual Summit on Biosimilars and Follow-On Biologics - Online Compendium

Price: $298.00
tax free
Item Number: C11Q014
In this workshop, hear both a payer and specialty pharmacy perspective on the current reimbursement environment for follow on biologics and its impact on distribution systems. Examine shifts in healthcare policy and how public and private payers are making decisions regarding coverage. In addition, understand the main drivers for biosimilar adoption and the need for extra comparative effectiveness studies (CER) to support safety and efficacy claims. Engage in discussion around how biosimilars are positioned for coding and reimbursement.

Key Questions to Be Addressed:
  • How are changes in healthcare policy impacting the reimbursement system?
  • What do private and public payers need to know to make decisions about biosimilars coverage?
  • How are specialty pharmacies and other sites of service approaching distribution of follow-on biologic products given the reimbursement climate?
  • What should a HCPCS coding strategy look like for biosimilars?

Product Reviews

(0 Ratings, 0 Reviews)